14-73654878-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_031427.4(DNAL1):c.35C>T(p.Ala12Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,537,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031427.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAL1 | NM_031427.4 | c.35C>T | p.Ala12Val | missense_variant | 2/8 | ENST00000553645.7 | NP_113615.2 | |
DNAL1 | NM_001201366.2 | c.-83C>T | 5_prime_UTR_variant | 3/9 | NP_001188295.1 | |||
DNAL1 | XM_017021679.3 | c.-83C>T | 5_prime_UTR_variant | 3/9 | XP_016877168.1 | |||
DNAL1 | XM_024449715.2 | c.-83C>T | 5_prime_UTR_variant | 3/9 | XP_024305483.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAL1 | ENST00000553645.7 | c.35C>T | p.Ala12Val | missense_variant | 2/8 | 1 | NM_031427.4 | ENSP00000452037.1 |
Frequencies
GnomAD3 genomes AF: 0.00000665 AC: 1AN: 150290Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000137 AC: 19AN: 1387518Hom.: 0 Cov.: 33 AF XY: 0.0000132 AC XY: 9AN XY: 683980
GnomAD4 genome AF: 0.00000665 AC: 1AN: 150290Hom.: 0 Cov.: 32 AF XY: 0.0000137 AC XY: 1AN XY: 73158
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia 16 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 11, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with DNAL1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces alanine with valine at codon 12 of the DNAL1 protein (p.Ala12Val). The alanine residue is moderately conserved and there is a small physicochemical difference between alanine and valine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at